Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Warrants Presented at Fair Value

v3.22.2
Warrants Presented at Fair Value
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
WARRANTS PRESENTED AT FAIR VALUE
NOTE 12:- Warrants presented at fair value

 

The Company’s outstanding warrants classified as a liability as of December 31, 2021 are as follows:

 

Outstanding     Exercise
price
    Issuance
year
   

Exercisable

through

    Fair value      
                               
  120,000     $ 0.92 (*)     2014       (*** )   $ 94     (****)
  905,555       0.17       2017       2022       5,841     Refer to Note 8.a.
  436,666       1.50       2017       2022       2     (****)
  33,332       1.20       2017       2022       0     Refer to Note 8.a.
  33,332       1.00       2017       2022       0     Refer to Note 8.a.
  675,926       (** )     2017       2022       54,731     (****)
  11,111       1.20       2017       2022       0     (****)
  1,659,971       0.17       2018       2022       11,359     Refer to Note 8.a.
  1,411,765       0.17       2019       2024       34,948     Refer to Note 8.e.
                                         
  5,287,658                             $ 106,975     (*****)

(*) Subject to changes as describe in the agreement.

 

(**) Less than $0.01.

 

(***) M&A or qualified PO as described in the agreement.

 

(****) Issued in connection with the 2014 through 2017 financing rounds.

 

(*****) Contains warrants presented at fair value within current liabilities of $17,296 and within non-current liabilities of $89,679.

 

 The Company’s outstanding warrants classified as a liability as of December 31, 2020 are as follows:

 

Outstanding     Exercise
price
    Issuance
year
   

Exercisable

through

    Fair value      
                               
  120,000     $ 0.92 (*)     2014       (**** )   $ 2,002     (******)
  374,001       1.50       2016       2021       91      
  905,555       0.17       2017       2022       108,090     Refer to Note 8.a.
  436,666       1.50       2017       2022       4,266     (******)
  33,332       1.20       2017       2022       485     Refer to Note 8.a.
  33,332       1.00       2017       2022       485     Refer to Note 8.a.
  675,926        (** )     2017       2022       155,839     (******)
  11,111       1.20       2017       2022       143      
  1,659,971       0.17       2018       2022       199,083     Refer to Note 8.a.
  29,411,765       0.17       2018       2021 (*****)     2,598,037      
  15,096,365        (*** )      (*** )     (*** )     1,333,511      
  1,411,765       0.17       2019       2024       204,242     Refer to Note 8.e.
  5,882,352       0.17       2019       2021       430,469      
  18,382,352       0.17       2019       2021 (*****)     1,623,773      
  13,970,587       0.17       2019       2021       1,334,255      
  246,294       0.17       2020       2021 (*****)     21,756      
  8,000,000     $ 0.26       2020       2022     $ 691,473      
                                         
  96,651,374                             $ 8,708,000     (*******)

 

(*) Subject to changes as describe in the agreement.

 

(**) Less than $0.01.

 

(***) Since the actual number of warrants cannot be determined as of December 31, 2020, the outstanding amounts were calculated based on an exercise price of $0.17, which results in the maximum potential amount of warrants.

 

(****) M&A or qualified PO as described in the agreement.

 

(*****) Two years from the registration statement or a PO, the earlier.

 

(******) Issued in connection with the 2014 through 2017 financing rounds.

 

(*******) Contains warrants presented at fair value within current liabilities of $7,343,894 and within non-current liabilities of $1,364,106.